跳至主要内容
临床试验/CTRI/2025/02/080301
CTRI/2025/02/080301尚未招募不适用

Randomized Clinical Study of Mashadya Taila Basti and Mashadya Tail Nasya in the Management of Kampavata with Reference to Parkinson’s Disease

Dr Pranali Jadhav1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年2月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Improvement in Clinical symptoms- subjective and objective parameters such as tremors, Bradykinesia, sthambha, gativikriti, avanamna, and vakavikriti after administeration of basti karma or nasya karma

研究概览

简要总结

Randomized clinical study comparing the efficacy of Mashadya taila basti (Rectal administration) and Mashadya taila nasya (Nasal administration) in managing Kampavata (Parkinson’s disease).

The study aims to assess and compare these treatment’s effect on symptoms like tremors, rigidity, gait impairement and cognitive issues.

A total 60 patients divided into 2 groups will undergo these therapies. The methodology includes ethical aprroval, informed consent, subjective and objective criteria. (example- Hoehn and Yahr scale).

The study highlights the integration of ayurvedic therapies for Parkinson’s and aims to explore their effectiveness compared to conventional treatments.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
50.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1.Clinically diagnosed patients fulfilling the subjective criteria of Kara-Pada Tala Kampa, Sthambha, Chesta Sangha, Vaka Vikruti and gait impairment.
  • 2.Patients of either sex.
  • 3.The patients age more than 50 years.
  • 4.Patients of Kampavata (PD) who were on a fixed dose of levodopa and fit for Basti and Nasya.
  • 5.Uncomplicated cases with classical symptoms of Parkinsons disease have been selected irrespective of caste, religion and profession.

排除标准

  • Patients less than 50 years.
  • Patients with severe systemic disorders such as uncontrolled Hypertension, Cardiac problem like Myocardial Infarction, Ischaemic Heart Disease, Cardiac Arrest, Cardiac Tamponade, Cardiomyopathy, Unstable Angina, etc., Tuberculosis, Leprosy, Paralysis, Malignant disease etc.
  • 3.Patients unfit for Basti and Nasya.

结局指标

主要结局

Improvement in Clinical symptoms- subjective and objective parameters such as tremors, Bradykinesia, sthambha, gativikriti, avanamna, and vakavikriti after administeration of basti karma or nasya karma

时间窗: Basti- 16 days | Nasya- 14 days

次要结局

  • Evaluate weather Mashadya taila basti is more effective than Mashadya taila nasya in managing symptoms of kampavata (Parkinsons disease)(Basti- 16 days)

研究者

发起方
Dr Pranali Jadhav
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DR PRANALI SUNILJADHAV

Padmashreee Dr D Y Patil School of ayurveda, Nerul, Thane, Navi Mumbai

研究点 (1)

Loading locations...

相似试验